{"symbol":"ABBV","fiscalQuarter":"Q3-2016","reportDate":"2016-10-28","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2016","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 6.28%","keyNumbers":[{"metric":"EPS","actual":"$1.21","expected":"N/A","surprise":"+0.33%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on driving long-term growth."],"summary":"Management expressed satisfaction with the EPS results, indicating a commitment to long-term growth strategies despite not providing specific guidance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise on EPS, which indicates better-than-expected profitability. However, the stock dropped by 6.28% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious about the company's future performance without clearer expectations.","metaDescription":"AbbVie Inc (ABBV) Q3 2016 earnings: EPS beat by 0.33%. Stock down 6.28%. Full breakdown."}}